US Stock MarketDetailed Quotes
CTXR Citius Pharmaceuticals
- 3.6000
- -0.5500-13.25%
Close Nov 27 16:00 ET
- 3.3904
- -0.2096-5.82%
Post 20:01 ET
27.82MMarket Cap-600P/E (TTM)
4.1094High3.5000Low421.06KVolume3.6000Open4.1500Pre Close1.56MTurnover5.82%Turnover RatioLossP/E (Static)7.73MShares26.750052wk High0.32P/B26.04MFloat Cap2.550052wk Low--Dividend TTM7.23MShs Float750.0000Historical High--Div YieldTTM14.68%Amplitude2.5500Historical Low3.7040Avg Price1Lot Size
Citius Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 12.68%-8.37M | 0.85%-7.79M | -27.17%-6.14M | -2.46%-29.06M | -7.39%-6.8M | -24.25%-9.58M | 18.75%-7.85M | -3.72%-4.82M | -16.95%-28.36M | -13.26%-6.33M |
| Net income from continuing operations | -24.70%-10.57M | 18.83%-8.54M | -156.88%-9.23M | 3.26%-32.54M | -24.44%-9.94M | 4.34%-8.48M | -39.21%-10.53M | 61.05%-3.59M | -45.92%-33.64M | -61.07%-7.99M |
| Depreciation and amortization | 7.82%52.85K | 8.16%52.07K | 8.10%51.01K | 8.15%194.32K | 8.04%49.97K | 8.09%49.02K | 8.26%48.14K | 8.20%47.19K | 8.98%179.68K | 8.14%46.25K |
| Deferred tax | 0.00%144K | 0.00%144K | 0.00%144K | 0.00%576K | -75.00%144K | --144K | --144K | --144K | --576K | --576K |
| Other non cash items | --109.95K | --98.08K | --76.15K | -73.03%102K | --0 | --0 | ---- | ---- | 456.18%378.2K | --104.32K |
| Change In working capital | 52.94%-1.16M | -315.48%-2.61M | 91.10%-233.46K | -1,772.40%-4.01M | -180.37%-126.19K | -2,508.46%-2.47M | 136.24%1.21M | -174.32%-2.62M | 108.82%239.56K | 95.35%-45.01K |
| -Change in prepaid assets | 45.89%-1.08M | -183.52%-1.15M | 100.97%25.01K | -4,430.59%-5.04M | 8.15%-57.19K | -595.21%-2M | -2,083.45%-405.48K | -1,283.16%-2.58M | 95.72%-111.18K | 95.76%-62.26K |
| -Change in payables and accrued expense | 39.55%-606.89K | -115.69%-377.13K | -10,541.30%-205.8K | 23.99%832.86K | -35.15%-568.91K | -1,906.25%-1M | 227.58%2.4M | -99.93%1.97K | 421.06%671.72K | -336.95%-420.95K |
| -Change in other current liabilities | -10.93%-54.82K | -10.93%-53.74K | -10.92%-52.68K | -11.14%-196.99K | -10.93%-51.64K | -11.22%-49.42K | -11.22%-48.44K | -11.22%-47.49K | -11.47%-177.24K | -11.22%-46.55K |
| -Change in other working capital | -0.01%579.59K | ---- | ---- | 374.60%394.73K | 13.78%551.54K | 19.70%579.67K | ---- | ---- | -157.25%-143.75K | 32.38%484.75K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 12.68%-8.37M | 0.85%-7.79M | -27.17%-6.14M | -2.46%-29.06M | -7.39%-6.8M | -24.25%-9.58M | 18.75%-7.85M | -3.72%-4.82M | -16.95%-28.36M | -13.26%-6.33M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 13.83M | -687 | 0 | 0 | ||||||
| Net common stock issuance | ---- | ---- | ---- | --13.8M | ---31.95K | ---- | ---- | ---- | --0 | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --31.27K | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -0.58%13.72M | ---- | ---- | --13.83M | ---687 | --13.8M | ---- | ---- | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -56.79%12.56M | -44.84%20.35M | -36.51%26.48M | -40.47%41.71M | -30.73%33.28M | -47.87%29.07M | -43.62%36.89M | -40.47%41.71M | 405.59%70.07M | -58.46%48.04M |
| Current changes in cash | 26.93%5.35M | 0.46%-7.79M | -27.17%-6.14M | 46.30%-15.23M | -7.40%-6.8M | 154.67%4.22M | 19.07%-7.82M | -3.72%-4.82M | -150.45%-28.36M | 86.11%-6.33M |
| End cash Position | -46.18%17.91M | -56.79%12.56M | -44.84%20.35M | -36.51%26.48M | -36.51%26.48M | -30.73%33.28M | -47.87%29.07M | -43.62%36.89M | -40.47%41.71M | -40.47%41.71M |
| Free cash flow | 12.68%-8.37M | 0.85%-7.79M | -27.17%-6.14M | -2.46%-29.06M | -7.39%-6.8M | -24.25%-9.58M | 18.75%-7.85M | -3.72%-4.82M | 55.86%-28.36M | 86.11%-6.33M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
